MaaT Pharma SA (MAAT.PA)
EUR 8.1
(1.0%)
EUR 8.1
(1.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 190 Thousand EUR | 304.26% |
| 2022 | 47 Thousand EUR | 42.42% |
| 2021 | 33 Thousand EUR | 134.02% |
| 2020 | -97 Thousand EUR | -453.52% |
| 2019 | 27.43 Thousand EUR | 2743700.0% |
| 2018 | 1.00 EUR | -100.0% |
| 2017 | 28.94 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 179 Thousand EUR | 0.0% |
| 2024 Q1 | 179 Thousand EUR | -5.79% |
| 2023 FY | 190 Thousand EUR | 304.26% |
| 2023 Q1 | 75 Thousand EUR | 59.57% |
| 2023 Q4 | 190 Thousand EUR | 0.0% |
| 2023 Q3 | 190 Thousand EUR | 153.33% |
| 2023 Q2 | 75 Thousand EUR | 0.0% |
| 2022 Q4 | 47 Thousand EUR | 0.0% |
| 2022 Q3 | 47 Thousand EUR | -27.69% |
| 2022 Q2 | 65 Thousand EUR | 0.0% |
| 2022 Q1 | 65 Thousand EUR | 96.97% |
| 2022 FY | 47 Thousand EUR | 42.42% |
| 2021 Q1 | 42 Thousand EUR | 143.3% |
| 2021 FY | 33 Thousand EUR | 134.02% |
| 2021 Q4 | 33 Thousand EUR | 0.0% |
| 2021 Q3 | 33 Thousand EUR | -21.43% |
| 2021 Q2 | 42 Thousand EUR | 0.0% |
| 2020 Q4 | -97 Thousand EUR | 0.0% |
| 2020 Q1 | - EUR | 0.0% |
| 2020 Q3 | - EUR | 0.0% |
| 2020 FY | -97 Thousand EUR | -453.52% |
| 2019 FY | 27.43 Thousand EUR | 2743700.0% |
| 2018 FY | 1.00 EUR | -100.0% |
| 2017 FY | 28.94 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 14.027% |
| ABIVAX Société Anonyme | 1.00 EUR | -18999900.0% |
| Adocia SA | 272 Thousand EUR | 30.147% |
| Aelis Farma SA | 53 Thousand EUR | -258.491% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 89.087% |
| genOway Société anonyme | 982.75 Thousand EUR | 80.667% |
| IntegraGen SA | 311.44 Thousand EUR | 38.995% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -15.416% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 117.138% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 84.484% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 259.428% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -108.791% |
| Valbiotis SA | 1 Million EUR | 81.095% |
| TheraVet SA | 123.34 Thousand EUR | -54.043% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -18999900.0% |
| argenx SE | 281.12 Million EUR | 99.932% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 84.921% |
| DBV Technologies S.A. | 1.00 USD | -18999900.0% |
| Galapagos NV | 73.97 Million EUR | 99.743% |
| Genfit S.A. | 4000.00 EUR | -4650.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -18999900.0% |
| Innate Pharma S.A. | 1.00 EUR | -18999900.0% |
| Inventiva S.A. | 417 Thousand EUR | 54.436% |
| MedinCell S.A. | -6.71 Million EUR | 102.83% |
| Nanobiotix S.A. | 200 Thousand EUR | 5.0% |
| Onward Medical N.V. | 936 Thousand EUR | 79.701% |
| Oryzon Genomics S.A. | 6029.00 EUR | -3051.435% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -48.438% |
| Pharming Group N.V. | 51.38 Million EUR | 99.63% |
| Poxel S.A. | 2.95 Million EUR | 93.572% |
| GenSight Biologics S.A. | 1.00 EUR | -18999900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.982% |
| Valneva SE | 44.46 Million EUR | 99.573% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -18999900.0% |